Retatrutide, a experimental dual activator of the GLP-1 receptor and glucose-dependent released polypeptide (GIP) receptor , is demonstrating promising data in initial patient studies. Ongoing research https://shopretatrutidepeptide.com/retatrutide-research-knowledge-hub/